NO20065404L - Polyvalente virusvektorer og et system for fremstilling av disse - Google Patents

Polyvalente virusvektorer og et system for fremstilling av disse

Info

Publication number
NO20065404L
NO20065404L NO20065404A NO20065404A NO20065404L NO 20065404 L NO20065404 L NO 20065404L NO 20065404 A NO20065404 A NO 20065404A NO 20065404 A NO20065404 A NO 20065404A NO 20065404 L NO20065404 L NO 20065404L
Authority
NO
Norway
Prior art keywords
production
virus vectors
polyvalent
polyvalent virus
expression cassettes
Prior art date
Application number
NO20065404A
Other languages
English (en)
Inventor
James M Wilson
Guangping Gao
Xiangyang Zhou
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of NO20065404L publication Critical patent/NO20065404L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/10Plasmid DNA
    • C12N2800/101Plasmid DNA for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/10Plasmid DNA
    • C12N2800/106Plasmid DNA for vertebrates
    • C12N2800/107Plasmid DNA for vertebrates for mammalian
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/70Vectors containing special elements for cloning, e.g. topoisomerase, adaptor sites
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/20Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Et system for å generere viral vektor som bærer to forskjellige ekspresjonskassetter er tilveiebrakt. Systemet benytter en unik polyvalent overføringsvektor som tillater effektiv delesjon og seleksjon av innsatte ekspresjonskassetter.
NO20065404A 2004-04-28 2006-11-23 Polyvalente virusvektorer og et system for fremstilling av disse NO20065404L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56594104P 2004-04-28 2004-04-28
PCT/US2005/014485 WO2005106002A2 (en) 2004-04-28 2005-04-27 Polyvalent viral vectors and a system for production thereof

Publications (1)

Publication Number Publication Date
NO20065404L true NO20065404L (no) 2007-01-17

Family

ID=34978744

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065404A NO20065404L (no) 2004-04-28 2006-11-23 Polyvalente virusvektorer og et system for fremstilling av disse

Country Status (16)

Country Link
US (1) US20070218536A1 (no)
EP (1) EP1743028A2 (no)
JP (1) JP5690038B2 (no)
KR (1) KR20070004877A (no)
CN (1) CN1965086B (no)
AU (1) AU2005238527B2 (no)
BR (1) BRPI0510385A (no)
CA (1) CA2562893A1 (no)
IL (1) IL178773A0 (no)
MA (1) MA28637B1 (no)
MX (1) MXPA06012511A (no)
NO (1) NO20065404L (no)
NZ (1) NZ550411A (no)
RU (1) RU2416646C2 (no)
SG (1) SG152267A1 (no)
WO (1) WO2005106002A2 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040136963A1 (en) * 2001-06-22 2004-07-15 The Trustees Of The University Of Pennsylvania Simian adenovirus vectors and methods of use
PL209133B1 (pl) * 2001-11-21 2011-07-29 Univ Pennsylvania Rekombinowany adenowirus, obejmująca go izolowana komórka gospodarza, oraz kompozycja i zastosowanie
RU2546247C2 (ru) * 2013-06-06 2015-04-10 Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ") Вакцина против чумы, аденовирусных инфекций, парвовирусного и коронавирусного энтеритов, лептоспироза и бешенства собак
AU2016360763B2 (en) * 2015-11-24 2020-11-05 Glaxosmithkline Intellectual Property Development Limited Stable cell lines for retroviral production
FR3044017B1 (fr) * 2015-11-24 2019-05-03 Glaxosmithkline Intellectual Property Development Limited Procede de transfection transitoire pour la production retrovirale
CN111479926A (zh) * 2017-10-16 2020-07-31 葛兰素史密丝克莱恩生物有限公司 具有两个表达盒的猿猴腺病毒载体
CN112206317B (zh) * 2020-10-12 2023-09-22 浙江省淡水水产研究所 一种草鱼出血病二价核酸菌蜕疫苗的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5880102A (en) * 1995-01-17 1999-03-09 Duke University Adenoviral vector system
US6096523A (en) * 1998-11-04 2000-08-01 University Of Georgia Research Foundation Transformation vector system
AU3117101A (en) * 2000-01-28 2001-08-07 Scripps Research Inst Synthetic internal ribosome entry sites and methods of identifying same
US20030108524A1 (en) * 2001-10-18 2003-06-12 Melissa Diagana Vectors for expressing multiple transgenes

Also Published As

Publication number Publication date
IL178773A0 (en) 2007-02-11
MXPA06012511A (es) 2006-12-15
WO2005106002A2 (en) 2005-11-10
KR20070004877A (ko) 2007-01-09
JP2007535326A (ja) 2007-12-06
CN1965086A (zh) 2007-05-16
CA2562893A1 (en) 2005-11-10
AU2005238527B2 (en) 2011-01-20
US20070218536A1 (en) 2007-09-20
MA28637B1 (fr) 2007-06-01
WO2005106002A3 (en) 2006-06-22
JP5690038B2 (ja) 2015-03-25
NZ550411A (en) 2009-08-28
EP1743028A2 (en) 2007-01-17
RU2006141839A (ru) 2008-06-10
RU2416646C2 (ru) 2011-04-20
AU2005238527A1 (en) 2005-11-10
BRPI0510385A (pt) 2007-11-13
SG152267A1 (en) 2009-05-29
CN1965086B (zh) 2012-12-26

Similar Documents

Publication Publication Date Title
NO20065404L (no) Polyvalente virusvektorer og et system for fremstilling av disse
DK1309575T3 (da) Biphenylderivater og deres anvendelse som aktivatorer af PPAR-gamma-receptorerne
BRPI0314814B8 (pt) anticorpo compreendendo uma variante de fc
ATE383804T1 (de) Kindgerechter einwegartikel
BR122018016045B8 (pt) proteína variante otimizada
NO20052887D0 (no) Pyridazinonderivater som GSK-3Beta inhibitorer.
ATE444467T1 (de) Eingebaute leuchte zur brandverhütung
ATE410571T1 (de) Verkleidungsplatte
DK1282611T3 (da) Substituerede phenylacetatamider og anvendelse deraf som glucokinaseaktivatorer
NO20081042L (no) PPAR aktive forbindelser
NO20044326D0 (no) Virale antigener
NO20042023L (no) Kinuklidinderivater fremgangsmate for flemstilling av disse og anvendelse av disse som m2- og/eller m3-muskarinreseptor-inhibitorer
ATE394298T1 (de) Fahrradlichtanlage
NO20051393L (no) Prosess og intermediater for fremstilling av tienopyrrol-derivater
NO20020571D0 (no) Peptider som blokkerer virusinfeksjonsevnen og fremgangsmåter for anvendelse av disse
NO20075998L (no) Tigecyklin og metoder til fremstilling av 9-aminominocyklin
NL1024881A1 (nl) PPAR-activatoren.
NO20006704D0 (no) Oppvarmet undersjöisk rörledning
HUP0400393A2 (hu) Eljárás vírusszaporításra
NO20053205L (no) Forbedret fremgangsmate for produksjon av vitamin B12.
BR0314689A (pt) Brinquedo para várias pessoas, e, brinquedo
FR2841450B3 (fr) Descriptif du presentoir vitrine plastique
NO20023412L (no) Fremgangsmåter, optiske registreringsanordninger som bruker slike fremgangsmåter og optiske registreringsmedium for bruk vedfremgangsmåtene og registreringsanordningene
Murray-Browne et al. The Serendiptichord: Reflections on the collaborative design process between artist and researcher
DK1365970T3 (da) Kurvbæreindretning til flasker og emne dertil

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application